Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization

Fertility and Sterility

Volumn 88, Issue 4, 2007, Pages 1010-1013

  Van Horne, Anne K ^a   Bates Jr , G Wright ^a   Robinson, Randal D ^a   Arthur, Nancy J ^a   Propst, Anthony M ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GANIRELIX; GONADOTROPIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HORMONE INHIBITION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY; OVARY FOLLICLE DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 34848899207     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.12.051     Document Type: Article

References (14)

1. Esposito M., Barnhart K., Coutifaris C., and Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 75 (2001) 519-524
2. Westergaard L., Larsen S., and Andersen C. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 15 (2000) 1003-1008
3. Fleming R., Lloyd F., Herbert M., Fenwick J., Griffiths T., and Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 13 (1998) 1788-1792
4. Filicori M., Cognigni G., Samara A., Melappioni S., Perri T., Cantelli B., et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod 8 (2002) 543-557
5. Filicori M., Fazleabas A., Hutaniemi I., Licth P., Rao C., Tesarik J., et al. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril 84 (2005) 275-283
6. Sullivan M.W., Stewart-Akers A., Krasnow J.S., Berga S.L., and Zelenik A.J. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 84 (1999) 228-232
7. Filicori M., Cognigni G.E., Tabarelli P., Taraborrelli D., Spettoli D., and Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87 (2002) 1156-1161
8. Filicori M., Cognigni G., Gamberini E., Parmegiani L., Troilo E., and Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 84 (2005) 394-401
9. Tarlatzis B.C., Fauser B.C., Kolibianakis E.M., Diedrich K., and Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 12 (2006) 333-340
10. Lisi F., Rinaldi L., Fishel S., Caserta D., Lisi R., and Campbell A. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril 83 (2005) 309-315
11. Cedrin-Durnerin I., Grange-Dujardin D., Laffy A., Parneix I., Massin N., Galey J., et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 19 (2004) 1979-1984
12. Bosch E., Escudero E., Crespo J., Simon C., Remohi J., and Pellicer A. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril 84 (2005) 1529-1532
13. De Placido G., Algviggi C., Perino A., Strina I., Lisi L., Fasolino A., et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in mormogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 20 (2005) 390-396
14. Acevedo B., Sanchez M., Gomez J., Cadros J., Ricciarelli E., and Hernandez E. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril 82 (2004) 343-347